Skip to main content
. 2022 Dec 6;2022(12):CD013601. doi: 10.1002/14651858.CD013601.pub2

Trovato 1983.

Study characteristics
Methods Study characteristics
  • Study design: parallel RCT

  • Study duration: not reported

  • Study follow‐up: 18 months

Participants Baseline characteristics
  • Country: Italy

  • Setting: not reported

  • Inclusion criteria: maintenance HD

  • Randomised number (intervention/control): 13/13

  • Dialysis modality: HD

  • Mean age ± SD (years): 45.54 ± 13.16

  • Sex (M/F): 13/13

  • Dialysis duration: not reported

  • Exclusion criteria: not reported

Interventions Intervention group
  • L‐carnitine (oral): 1500 mg/day for 18 months


Control group
  • Placebo

Outcomes Outcomes relevant to this review
  • Anaemia‐related markers: HCT, EPO dose

Notes Other information
  • Abstract‐only publication

  • Funding source: not reported

Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Study was described as randomised; method of randomisation was not reported
Allocation concealment (selection bias) Unclear risk Insufficient information to permit judgement
Blinding of participants and personnel (performance bias) High risk Quote: "single‐blind"
Blinding of outcome assessment (detection bias)
Anaemia‐related markers Low risk The outcome measurement is not likely to be influenced by lack of blinding
Incomplete outcome data (attrition bias)
Anaemia‐related markers Unclear risk Insufficient information to permit judgement
Selective reporting (reporting bias) Unclear risk The study protocol is not available
Other bias Unclear risk Insufficient information to permit judgement